Organigram Receives Nasdaq Notice Over Share Price Below $1

what happened

Cannabis producer Organigram Global, as reported by TradingView, has been told by Nasdaq that its common shares fall short of the $1.00 minimum bid for continued listing on the Nasdaq Global Select Market. The letter, dated November 11, 2026, followed a stretch of 30 consecutive business days with the stock trading under $1.00.

The notice does not change trading in the shares for now. The company has until May 10, 2027 to bring its price back above the threshold, which means closing at or above $1.00 for at least 10 straight business days. If that does not happen, it may qualify for an extra 180-day window by moving to the Nasdaq Capital Market; otherwise, delisting proceedings could start, subject to appeal rights. Its Toronto Stock Exchange listing is unaffected.

why it matters

Notices like this concern the company itself and rarely move the broader market, but for a stock trading near the $1 level they flag a risk of listing downgrade or delisting. For investors, the key question is whether the share price can hold above $1 before May 2027.

tags

instruments